San Francisco, CA (PRWEB) November 02, 2013
American College of Traditional Chinese Medicine (ACTCM) Doctoral Program Director Dr. Carla Wilson recently presented groundbreaking research in the field of Traditional Chinese Medicine (TCM) at the 10th Congress of World Medicine held in San Francisco last month. In October, Dr. Wilson also won a New Investigator Award for this research at the 10th International Conference of the Society for Integrative Oncology in Vancouver.
The research was focused on an integrative approach to treating HPV-related cancer. The main goal of the clinical trials, held at the University of California at San Francisco Comprehensive Cancer Center, was to compare the effects of a Chinese topical herbal medicine cream to a placebo cream in the treatment of precancerous anal lesions caused by HPV in order to prevent their progression to anal cancer.
“HPV-related cancer is a growing health concern for immunocompromised people, typically those with HIV,” said Dr. Wilson. “Prior to the development of this cancer, a person develops a condition known as a high-grade squamous intraepithelial lesion (HSIL). Treatment of the HSIL can prevent the progression to cancer, but the current treatments are highly invasive and expensive. A new, noninvasive alternative could have a very high impact on the prevention of anal cancer.”
Applying an innovative mixed methods approach not typically used in traditional university research settings, researchers were able to use both qualitative and quantitative methodologies to produce the most revealing results possible.
Preliminary qualitative data gathered shows that 80% of study participants reported an increase in understanding of self-care and 76% of participants in this double-blind study indicated they would continue to apply the herbal cream if given the opportunity.
The data also reveals modification of harmful habits, changes in lifestyle, and increased confidence in considering alternative approaches to cancer care.
This study represents a major therapeutic advancement in the prevention of HPV-related cancers through the treatment of anal HSIL, cervical HSIL and vulvar HSIL, as well as the treatment of early-stage cancer, without the costly and invasive method of surgery and other ablative therapies.
“While this is exploratory research, these outcomes lend credibility to the Chinese medicine paradigm of Whole Systems Research,” said Dr. Wilson. “Investigating anal cancer treatment through translational research and applying the lens of Chinese medicine is a forward-thinking and unique approach that holds promise for future mixed methods research.”
Such positive findings may serve as a breakthrough for application to other types of epithelial cancers, and could guide other researchers to consider the use of both qualitative and quantitative methods as an integrative cancer study model in the future.
Results from the quantitative portion of this study, as well as biomarkers, have not yet been released.
For more information about programs at ACTCM and how to register, visit http://www.actcm.edu/ .
About The American College of Traditional Chinese Medicine
ACTCM provides professional graduate degree programs in Traditional Chinese Medicine (TCM) including a Master of Science in TCM (MSTCM) and Doctor of Acupuncture and Oriental Medicine (DAOM), as well as graduate certificate programs in TCM pediatrics, TCM classics and Medical Qigong. ACTCM is located in San Francisco, California, with education and clinical facilities that offer procedures for stress relief, pain management, weight loss and more. ACTCM has three Bay Area alternative medicine clinic externship sites, including California Pacific Medical Center (CPMC), Haight Ashbury Free Medical Clinic (HAFMC) and Life Long Berkeley Primary Care (LLBPC). ACTCM is accredited by the Accreditation Commission for Acupuncture and Oriental Medicine (ACAOM).